Summary: A study uncovered a novel neuroimmune mechanism explaining how rapid-acting antidepressants, including ketamine and psychedelics, alleviate treatment-resistant…
Summary: For decades, the standard treatment for depression relied on antidepressants that targeted monoamines like serotonin and norepinephrine—drugs…